Oxaliplatin
Links shared publicly online about this topic
Oncology Medical News about Oxaliplatin
mdlinx.com — “Oxaliplatin-Mediated Increase in Spleen Size As a Biomarker for the Development of Hepatic Sinusoidal Injury” View full resource at mdlinx.com
Most Recently Shared on May 11, 2010 at 6:21 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oxaliplatin-Mediated Increase in Spleen Size As a Biomarker for the Development of Hepatic Sinusoidal Inj... http://bit.ly/cWjuzz #oncology
Oxaliplatin-Related Ocular Toxicity
content.karger.com — “We report the case of a 52-year-old woman with advanced colorectal cancer who was treated with oxaliplatin on a FOLFOX schedule. After 3 cycles of chemotherapy, she started to complain of visual loss, altered color vision and neurological symptoms. Due to the suspicion of ocular and neurological toxicity, antineoplastic treatment was stopped. Her visual field showed a concentric bilateral scotoma and the electrooculogram test revealed severe impairment of the retinal pigment epithelium. Visual a” View full resource at content.karger.com
Most Recently Shared on November 20, 2010 at 8:27 pm By:
Oxaliplatin-Related Ocular Toxicity: Case Rep Oncol 2010;3:423–427 (DOI:10.1159/000322675) (Source: Karger Pub... http://bit.ly/bYXMEQ
APP Pharmaceuticals Receives Approval For Lyophilized Oxaliplatin For Injection
medicalnewstoday.com — “APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced it received approval from the U.S. Food and Drug Administration to ma” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2010 at 2:10 pm By:
MNT Drug Approvals Health News
APP Pharmaceuticals Receives Approval For Lyophilized Oxaliplatin For Injection http://mnt.to/3DG5 #regulatory
ingentaconnect Oxaliplatin: Bronchiolitis obliterans organising pneumonia: case ...
ingentaconnect.com — “ingentaconnect Oxaliplatin: Bronchiolitis obliterans organising pneumonia: case ...” View full resource at ingentaconnect.com
Most Recently Shared on September 13, 2010 at 1:27 pm By:
Oxaliplatin: Bronchiolitis obliterans organising pneumonia: case report: (Source: Reactions) http://bit.ly/9Mt4iQ
Roche - Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
www-origin2.roche.com — “Roche - Xeloda in combination with oxaliplatin shown to be effective in early colon cancer” View full resource at www-origin2.roche.com
Most Recently Shared on July 20, 2009 at 2:10 pm By:
eyeonfda Pharma and Health Lawyer
Xeloda in combination with oxaliplatin shown to be effective in early colon cancer http://bit.ly/14KIs0
More Evidence for Oxaliplatin as Colon Cancer Chemotherapy --Doctors Lounge
doctorslounge.com — “More Evidence for Oxaliplatin as Colon Cancer Chemotherapy --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on January 21, 2012 at 12:16 am By:
More Evidence for Oxaliplatin as Colon Cancer Chemotherapy http://t.co/JzIdwZe9 #health #medicine
IngentaConnect Oxaliplatin: Bronchiolitis obliterans organising pneumonia in an ...
ingentaconnect.com — “IngentaConnect Oxaliplatin: Bronchiolitis obliterans organising pneumonia in an ...” View full resource at ingentaconnect.com
Most Recently Shared on June 13, 2010 at 7:03 pm By:
Oxaliplatin: Bronchiolitis obliterans organising pneumonia in an elderly patient: case report: (Source: Reactions)... http://bit.ly/cCeK9P
Jury Still Out on Oxaliplatin for Early-Stage Colon, Rectal Cancers
onclive.com — “Adding oxaliplatin to 5-fluorouracil before and after surgery for the treatment of locally advanced rectal cancer is demonstrating significant benefit.” View full resource at onclive.com
Most Recently Shared on July 26, 2011 at 1:36 pm By:
Jury Still Out on Oxaliplatin for Early-Stage Colon, Rectal Cancers http://t.co/TjP29B2
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA
oncologynurseadvisor.com — “The combination of oxaliplatin and doxorubicin showed promising efficacy in either platinum-sensitive or platinum-resistant recurrent ovarian cancer, as reported by Ilya Pokateav, MD, from the Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, and colleagues at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 5, 2011 at 5:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability http://goo.gl/fb/ldXlW
Study showed oxaliplatin improved colon cancer patient survival
medicalxpress.com — “Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published Jan. 20 in the Journal of the National Cancer Institute.” View full resource at medicalxpress.com
Most Recently Shared on January 20, 2012 at 10:52 pm By:
Study showed oxaliplatin improved colon cancer patient survival http://t.co/W9a6f2ID
More Evidence for Oxaliplatin as Colon Cancer Chemotherapy - Yahoo! News
news.yahoo.com — “From Yahoo! News: FRIDAY, Jan. 20 (HealthDay News) -- Adding oxaliplatin to a standard chemotherapy regimen boosts survival rates for patients with advanced colon cancer, according to a new study that bolsters previous research on the drug by looking at a broader group of patients.” View full resource at news.yahoo.com
Most Recently Shared on January 21, 2012 at 12:25 am By:
More Evidence for Oxaliplatin as Colon Cancer Chemotherapy: FRIDAY, Jan. 20 (HealthDay News) -- Adding oxaliplat... http://t.co/RHCpYMrW
Mayo Clinic - Study Shows that Administering Calcium and Magnesium Effectively Reduces Neurological Sensitivity Caused by the Chemotherapy Drug Oxaliplatin
mayoclinic.org — “Mayo Clinic - Study Shows that Administering Calcium and Magnesium Effectively Reduces Neurological Sensitivity Caused by the Chemotherapy Drug Oxaliplatin” View full resource at mayoclinic.org
Most Recently Shared on May 16, 2008 at 1:23 pm By:
Mayo Clinic News Study Shows that Administering Calcium and Magnesium Effectively Redu.. http://tinyurl.com/6as5up
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study : The Lancet Oncology
thelancet.com — “Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study. By - Dr Birgit Gruenberger MD, Johannes Schueller MD, Ute Heubran...” View full resource at thelancet.com
Most Recently Shared on November 29, 2010 at 6:42 pm By:
Thomas J Reid MD PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Biliary tract cancer: Phase II study of Cetuximab + GemOx http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70247-3/abstract
Roche - Xeloda in combination with oxaliplatin approved in Europe for the adjuvant treatment of patients with early colon cancer
roche.com — “Roche - Xeloda in combination with oxaliplatin approved in Europe for the adjuvant treatment of patients with early colon cancer” View full resource at roche.com
Most Recently Shared on March 30, 2010 at 5:04 am By:
News: Xeloda in combination with oxaliplatin approved in Europe for the adjuvant treatment of patients with early... http://dlvr.it/NCfG
Oncology News - Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib |3987856
mdlinx.com — “Oncology Medical Article: Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib” View full resource at mdlinx.com
Most Recently Shared on March 21, 2012 at 11:15 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-tre... http://t.co/jGsbqniX #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Toxins OW
Organizing toxins and chemicals resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
